JAK2 and glioblastoma: Subtype selectivity in targeting kinases such as JAK2 and SIK1 in GBM will most likely be important in the clinic since we know that JAK and SIK subtypes play important roles in processes such as macrophage differentiation, dendritic cell function and innate immunity [104,105,113].